These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons. Cho DH; Lee EJ; Kwon KJ; Shin CY; Song KH; Park JH; Jo I; Han SH J Neurochem; 2013 Sep; 126(5):685-95. PubMed ID: 23581463 [TBL] [Abstract][Full Text] [Related]
23. Regulation of CRMP2 by Cdk5 and GSK-3β participates in sevoflurane-induced dendritic development abnormalities and cognitive dysfunction in developing rats. Liao Z; Huang Z; Li J; Li H; Miao L; Liu Y; Zhang J; Xu Y; Li Y Toxicol Lett; 2021 May; 341():68-79. PubMed ID: 33548343 [TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau. Sotiropoulos I; Catania C; Riedemann T; Fry JP; Breen KC; Michaelidis TM; Almeida OF J Neurochem; 2008 Oct; 107(2):385-97. PubMed ID: 18691381 [TBL] [Abstract][Full Text] [Related]
25. The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease. Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O Antioxid Redox Signal; 2012 Sep; 17(6):860-77. PubMed ID: 22360429 [TBL] [Abstract][Full Text] [Related]
27. Interaction of Tau with Fe65 links tau to APP. Barbato C; Canu N; Zambrano N; Serafino A; Minopoli G; Ciotti MT; Amadoro G; Russo T; Calissano P Neurobiol Dis; 2005 Mar; 18(2):399-408. PubMed ID: 15686969 [TBL] [Abstract][Full Text] [Related]
28. PKA modulates GSK-3beta- and cdk5-catalyzed phosphorylation of tau in site- and kinase-specific manners. Liu F; Liang Z; Shi J; Yin D; El-Akkad E; Grundke-Iqbal I; Iqbal K; Gong CX FEBS Lett; 2006 Nov; 580(26):6269-74. PubMed ID: 17078951 [TBL] [Abstract][Full Text] [Related]
29. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Chauhan NB; Siegel GJ; Feinstein DL Neuropharmacology; 2005 Jan; 48(1):93-104. PubMed ID: 15617731 [TBL] [Abstract][Full Text] [Related]
30. Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A. Li L; Liu Z; Liu J; Tai X; Hu X; Liu X; Wu Z; Zhang G; Shi M; Zhao G Neurobiol Dis; 2013 Jun; 54():320-8. PubMed ID: 23321003 [TBL] [Abstract][Full Text] [Related]
31. Divergent roles of GSK3 and CDK5 in APP processing. Ryder J; Su Y; Liu F; Li B; Zhou Y; Ni B Biochem Biophys Res Commun; 2003 Dec; 312(4):922-9. PubMed ID: 14651959 [TBL] [Abstract][Full Text] [Related]
32. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro. Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556 [TBL] [Abstract][Full Text] [Related]
33. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Liu HL; Zhao G; Zhang H; Shi LD Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591 [TBL] [Abstract][Full Text] [Related]
34. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells. Zhang X; Yin WK; Shi XD; Li Y Eur J Pharm Sci; 2011 Apr; 42(5):540-6. PubMed ID: 21352912 [TBL] [Abstract][Full Text] [Related]
35. Role of GSK-3beta activation and alpha7 nAChRs in Abeta(1-42)-induced tau phosphorylation in PC12 cells. Hu M; Waring JF; Gopalakrishnan M; Li J J Neurochem; 2008 Aug; 106(3):1371-7. PubMed ID: 18485099 [TBL] [Abstract][Full Text] [Related]
36. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice. Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765 [TBL] [Abstract][Full Text] [Related]
37. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883 [TBL] [Abstract][Full Text] [Related]
38. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium. Jordà EG; Verdaguer E; Canudas AM; Jiménez A; Garcia de Arriba S; Allgaier C; Pallàs M; Camins A Neuroscience; 2005; 134(3):1001-11. PubMed ID: 15979805 [TBL] [Abstract][Full Text] [Related]
39. Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats. Li G; Liu T; Kong X; Wang L; Jin X J Mol Neurosci; 2014 Sep; 54(1):92-9. PubMed ID: 24563226 [TBL] [Abstract][Full Text] [Related]
40. Mice lacking phosphatase PP2A subunit PR61/B'delta (Ppp2r5d) develop spatially restricted tauopathy by deregulation of CDK5 and GSK3beta. Louis JV; Martens E; Borghgraef P; Lambrecht C; Sents W; Longin S; Zwaenepoel K; Pijnenborg R; Landrieu I; Lippens G; Ledermann B; Götz J; Van Leuven F; Goris J; Janssens V Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6957-62. PubMed ID: 21482799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]